Ponatinib-d8 |
Catalog No.GC45828 |
Le ponatinib D8 (AP24534 D8) est un ponatinib marqué au deutérium. Le ponatinib (AP24534) est un inhibiteur de kinase multi-ciblé actif par voie orale avec des IC50 de 0,37 nM, 1,1 nM, 1,5 nM, 2,2 nM et 5,4 nM pour Abl, PDGFRα, VEGFR2, FGFR1 et Src, respectivement.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1562993-37-6
Sample solution is provided at 25 µL, 10mM.
Review for Ponatinib-d8
Average Rating: 5
(Based on Reviews and 23 reference(s) in Google Scholar.)Review for Ponatinib-d8
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *